Back to GetFilings.com



Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 10-Q

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarter ended September 30, 2003

OR

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______________to _______________

COMMISSION FILE NUMBER 000-31687

EVERGREEN SOLAR, INC.

(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
     
DELAWARE   04-3242254
(STATE OR OTHER JURISDICTION OF   (I.R.S. EMPLOYER
INCORPORATION OR ORGANIZATION)   IDENTIFICATION NUMBER)

259 Cedar Hill Street
Marlboro, Massachusetts 01752

(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)

(508) 357-2221
(REGISTRANT’S TELEPHONE NUMBER, INCLUDING AREA CODE)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes [X] No [   ]

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).

Yes [   ] No [X]

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: As of November 1, 2003 there were 11,647,583 shares of common stock outstanding.


 


TABLE OF CONTENTS

PART I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
Condensed Consolidated Balance Sheets
Condensed Consolidated Statements of Operations
Condensed Consolidated Statements of Cash Flows
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK
ITEM 4. CONTROLS AND PROCEDURES
PART II. OTHER INFORMATION
ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K
SIGNATURES
EX-31.1 SECTION 302 CERTIFICATION OF THE C.E.O.
EX-31.2 SECTION 302 CERTIFICATION OF THE C.F.O.
EX-32.1 SECTION 906 CERTIFICATION OF THE C.E.O.
EX-32.2 SECTION 906 CERTIFICATION OF THE C.F.O.


Table of Contents

EVERGREEN SOLAR, INC.
QUARTERLY REPORT ON FORM 10-Q
FOR THE QUARTER ENDED SEPTEMBER 30, 2003

TABLE OF CONTENTS

             
        Page
       
PART I – FINANCIAL INFORMATION
       
 
ITEM 1: FINANCIAL STATEMENTS
       
   
Unaudited Condensed Consolidated Balance Sheets at December 31, 2002 and September 30, 2003
    3  
   
Unaudited Condensed Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2003 and 2002
    4  
   
Unaudited Condensed Consolidated Statements of Cash Flows for the Three and Nine Months Ended September 30, 2003 and 2002
    5  
   
Notes to Condensed Consolidated Financial Statements
    6  
 
ITEM 2: MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
    12  
 
ITEM 3: QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
    25  
 
ITEM 4: CONTROLS AND PROCEDURES
    25  
PART II – OTHER INFORMATION
       
 
ITEM 6: EXHIBITS AND REPORTS ON FORM 8-K
    26  
SIGNATURES
       
EXHIBIT INDEX
       

2


Table of Contents

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

Evergreen Solar, Inc.
Condensed Consolidated Balance Sheets
(in thousands, except share data)
(unaudited)

                     
        September 30,   December 31,
        2003   2002
       
 
Assets
               
Current assets:
               
 
Cash and cash equivalents
  $ 3,977     $ 1,194  
 
Marketable securities
    20,535       7,289  
 
Accounts receivable, net of allowance for doubtful accounts of $254 and $140 at September 30, 2003 and December 31, 2002, respectively
    2,376       2,848  
 
Interest receivable
    295       57  
 
Inventory
    1,945       2,194  
 
Other current assets
    611       1,012  
 
 
   
     
 
   
Total current assets
    29,739       14,594  
Restricted cash
    414       464  
Fixed assets, net
    21,355       16,905  
 
 
   
     
 
Total assets
  $ 51,508     $ 31,963  
 
 
   
     
 
Liabilities, convertible preferred stock and stockholders’ equity
               
Current liabilities:
               
 
Accounts payable
  $ 1,275     $ 861  
 
Accrued employee compensation
    488       569  
 
Accrued warranty
    410       326  
 
Other accrued expenses
    282       294  
 
 
   
     
 
   
Total current liabilities
    2,455       2,050  
Convertible preferred stock
               
   
Series A, $.01 par value, 26,227,668 and 0 shares authorized, 26,004,454 and 0 issued and outstanding at September 30, 2003 and December 31, 2002, respectively
    30,232        
Stockholders’ equity:
               
Common stock, $0.01 par value, 70,000,000 and 30,000,000 shares authorized, 11,647,583 and 11,410,826 issued and outstanding at September 30, 2003 and December 31, 2002, respectively
    116       114  
Additional paid-in capital
    70,031       71,508  
Accumulated other comprehensive income (loss)
    (32 )     7  
Accumulated deficit
    (51,141 )     (41,356 )
Deferred compensation
    (153 )     (360 )
 
 
   
     
 
 
Total stockholders’ equity
    18,821       29,913  
 
 
   
     
 
Total liabilities, convertible preferred stock and stockholders’ equity
  $ 51,508     $ 31,963  
 
 
   
     
 

The accompanying notes are an integral part of these financial statements.

3


Table of Contents

Evergreen Solar, Inc.
Condensed Consolidated Statements of Operations
(in thousands, except per share data)
(unaudited)

                                     
        Three months ended   Nine months ended
        September 30,   September 30,
        2003   2002   2003   2002
       
 
 
 
Revenues:
                               
 
Product revenues
  $ 2,642     $ 1,461     $ 6,368     $ 3,448  
 
Research revenues
    463       641       1,352       1,084  
 
 
   
     
     
     
 
Total revenues
    3,105       2,102       7,720       4,532  
 
 
   
     
     
     
 
Operating expenses:
                               
 
Cost of product revenues
    4,061       3,041       10,969       8,861  
 
Research and development expenses, including costs of research revenues
    1,087       935       2,872       2,776  
 
Selling, general and administrative expenses
    1,301       991       3,821       3,108  
 
 
   
     
     
     
 
Total operating expenses
    6,449       4,967       17,662       14,745  
 
 
   
     
     
     
 
Operating loss
    (3,344 )     (2,865 )     (9,942 )     (10,213 )
 
Interest income, net
    83       133       157       585  
 
 
   
     
     
     
 
Net loss
    (3,261 )     (2,732 )     (9,785 )     (9,628 )
 
Accretion and dividends on Series A convertible preferred stock
    (747 )           (12,802 )      
 
 
   
     
     
     
 
Net loss attributed to common stockholders
    (4,008 )     (2,732 )     (22,587 )     (9,628 )
 
Other comprehensive income (loss):
                               
   
Unrealized gain (loss) on marketable securities
    22       (46 )     (39 )     47  
 
 
   
     
     
     
 
Comprehensive loss
  $ (3,986 )   $ (2,778 )   $ (22,626 )   $ (9,581 )
 
 
   
     
     
     
 
Net loss per common share (basic and diluted)
  $ (0.35 )   $ (0.24 )   $ (1.97 )   $ (0.84 )
Weighted average shares used in computing basic and diluted net loss per common share
    11,497       11,408       11,440       11,403  

The accompanying notes are an integral part of these financial statements.

4


Table of Contents

Evergreen Solar, Inc.
Condensed Consolidated Statements of Cash Flows
(in thousands)
(unaudited)

                       
          Nine Months Ended
          September 30,
          2003   2002
         
 
Cash flows from operating activities:
               
 
Net loss
  $ (9,785 )   $ (9,628 )
Adjustments to reconcile net loss to net cash used in operating activities:
               
   
Depreciation expense
    1,544       1,476  
   
Bad debt expense
    114        
   
Amortization of bond premiums
    216       233  
   
Write-off of fixed assets
          43  
   
Issuance of stock options to consultants
    37        
   
Compensation expense associated with employee stock options
    207       215  
   
Changes in operating assets and liabilites:
               
     
Inventory
    249       (1,563 )
     
Interest receivable
    (238 )     190  
     
Accounts receivable
    358       (2,012 )
     
Other current assets
    401       (82 )
     
Accounts payable
    414       56  
     
Accrued expenses
    75       200  
 
 
   
     
 
Net cash used in operating activities
    (6,408 )     (10,872 )
 
 
   
     
 
Cash flows from investing activities:
               
 
Purchases of fixed assets
    (5,994 )     (1,454 )
 
Restricted cash
    50        
 
Purchases of marketable securities
    (22,201 )     (9,475 )
 
Proceeds from sale and maturity of marketable securities
    8,700       20,180  
 
 
   
     
 
Net cash provided by (used in) investing activities
    (19,445 )     9,251  
 
 
   
     
 
Cash flows from financing activities:
               
 
Issuance of Series A convertible preferred stock
    29,375        
 
Financing costs on issuance of Series A convertible preferred stock
    (849 )      
 
Proceeds from issuance of common stock warrant
    100        
 
Proceeds from exercise of stock options and shares purchased under Employee Stock Purchase Plan
    10       14  
 
 
   
     
 
Net cash flow provided by financing activities
    28,636       14  
 
 
   
     
 
Net increase (decrease) in cash and cash equivalents
    2,783       (1,607 )
Cash and cash equivalents at beginning of period
    1,194       2,554  
 
 
   
     
 
Cash and cash equivalents at end of period
  $ 3,977     $ 947  
 
 
   
     
 
Supplemental cash flow information:
               
 
Taxes paid
    13       36  
 
Non-cash Series A convertible preferred stock dividends earned
    1,114        
 
Non-cash conversion of Series A convertible preferred stock to common
    257        

The accompanying notes are an integral part of these financial statements.

5


Table of Contents

EVERGREEN SOLAR, INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

1.     Basis of Presentation

The accompanying condensed consolidated interim financial statements of Evergreen Solar, Inc. (“Evergreen Solar” or the “Company”) are unaudited and have been prepared on a basis substantially consistent with the Company’s audited financial statements for the year ended December 31, 2002. The condensed consolidated interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information. Consequently, these statements do not include all disclosures normally required by generally accepted accounting principles for annual financial statements. These condensed consolidated interim financial statements should be read in conjunction with the Company’s audited financial statements for the year ended December 31, 2002, which are contained in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2002, which was filed with the Securities and Exchange Commission on March 27, 2003. The unaudited condensed consolidated interim financial statements, in the opinion of management, reflect all adjustments (consisting only of normal recurring accruals) necessary for a fair presentation of the financial position at September 30, 2003, the results of operations for the three and nine month periods ended September 30, 2003 and 2002, and the cash flows for the nine month periods ended September 30, 2003 and 2002. The balance sheet at December 31, 2002 has been derived from audited financial statements as of that date. The results of operations for the interim periods are not necessarily indicative of the results of operations to be expected for any other interim period or for the full fiscal year ending December 31, 2003.

The Company’s preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reported periods. Estimates are used when accounting for the collectibility of receivables, valuing deferred tax assets, provisions for warranty claims and inventory obsolescence.

The Company has historically financed operations and met capital expenditures requirements primarily through sales of capital stock and, to a lesser extent, research and product revenues. The first of the Marlboro facility’s two manufacturing lines became operational in 2001. As more fully described in Note 8 “Stockholders’ Equity,” on May 15, 2003, the Company consummated the private placement transaction contemplated by the purchase agreement entered into on March 21, 2003 with certain investors to raise $29,475,000 through the issuance of 26,227,668 shares of Series A convertible preferred stock and the sale of a warrant to purchase 2,400,000 shares of common stock. The proceeds to the Company, net of financing expenses of approximately $849,000, were approximately $28.6 million. The Company expects to use the net proceeds from this transaction to fund the construction of the second manufacturing line and other operations of the Company. The Company expects portions of the second manufacturing line to become operational in late 2003 and that it will be completed in 2004. As of September 30, 2003, our outstanding commitments for capital expenditures were approximately $3.3 million. Nearly all of its commitments for capital expenditures are associated with infrastructure improvements and equipment purchases for its manufacturing facility. In addition to the current capital commitments, substantial further capital expenditures will be required over the next twelve to eighteen months to increase the capacity at its manufacturing facility to its target level of 10 to 14 megawatts for both lines.

The Company may need additional financing to execute its business plan if the Company needs to respond to business contingencies such as the need to enhance its operating infrastructure, respond to competitive pressures and acquire complementary businesses or necessary technologies. The Company does not know whether it will be able to raise additional financing on favorable financing terms. If adequate funds are not available or are not available on acceptable terms, the Company’s ability to fund its operations, develop and expand its manufacturing operations and distribution network, or otherwise respond to competitive pressures would be significantly limited.

2.     Net Loss per Common Share

The Company computes net loss per common share in accordance with SFAS No. 128, “Earnings Per Share” (“SFAS 128”), and SEC Staff Accounting Bulletin No. 98 (“SAB 98”). Under the provisions of SFAS 128 and SAB 98, basic net loss per common share is computed by dividing net loss attributable to common stockholders by the weighted average number of common shares outstanding during the period. The calculation of diluted net loss per common share for the three and nine month periods ended September 30, 2003 and 2002 does not include 30,042,944 and 1,557,511 potential shares of common stock equivalents outstanding at September 30, 2003 and 2002, respectively, as their inclusion would be antidilutive.

6


Table of Contents

3.     Inventory

A summary of inventories is as follows:

                 
    September 30,   December 31,
    2003   2002
   
 
Raw materials
  $ 1,318,000     $ 1,236,000  
Work-in-process
    30,000       148,000  
Finished goods
    597,000       810,000  
 
   
     
 
 
  $ 1,945,000     $ 2,194,000  
 
   
     
 

4.     Cash and Investments

Cash and cash equivalents consist of cash and highly liquid investments with maturities of three months or less from the date of purchase and whose carrying amount approximates fair value.

The Company’s investments are classified as available-for-sale. At September 30, 2003 and December 31, 2002 the Company held US government agency bonds, treasury notes, municipal bonds, corporate bonds and commercial paper. The investments generally mature within one year from the date of purchase and are carried at market value. Cash and investments have increased significantly since December 31, 2002 due to the Company’s Series A convertible preferred stock and warrant financing that closed on May 15, 2003.

5.     Fixed Assets

Fixed assets consisted of the following at September 30, 2003 and December 31, 2002 (in thousands):

                         
             
    Useful   September   December
    Life   2003   2002
   
 
 
Laboratory and manufacturing equipment
  3-7 years   $ 11,764     $ 10,997  
Computer and office equipment
  3-7 years     258       245  
Leasehold improvements
  Lesser of 15 to 20 years or lease term     6,584       6,273  
Assets under construction
            7,672       2,769  
 
           
     
 
 
            26,278       20,284  
Less accumulated depreciation
            (4,923 )     (3,379 )
 
           
     
 
 
          $ 21,355     $ 16,905  
 
           
     
 

Fixed assets have increased significantly since December 31, 2002 due to the Company’s current production capacity expansion program. The Company expects portions of the second manufacturing line to become operational in late 2003 and that it will be completed in 2004. As of September 30, 2003, the Company’s outstanding commitments for capital expenditures were approximately $3.3 million. Nearly all of its commitments for capital expenditures are associated with infrastructure improvements and equipment purchases for its manufacturing facility. In addition to the current capital commitments, substantial further capital expenditures will be required over the next twelve to eighteen months to increase the capacity at our manufacturing facility to our target level of 10 to 14 megawatts for both lines.

6.     Guarantor Arrangements

In November 2002, the FASB issued FASB Interpretation No. 45 (“FIN 45”) “Guarantor’s Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others an interpretation of FASB Statements No. 5, 57, and 107 and rescission of FASB Interpretation No. 34.” FIN 45 requires that a guarantor recognize, at the inception of a guarantee, a liability for the fair value of the obligation undertaken by issuing the guarantee. The accounting requirements for the initial recognition of guarantees are applicable on a prospective basis for guarantees issued or modified after December 31, 2002. The disclosure requirements are effective for all guarantees outstanding, regardless of when they were issued or modified, during the first quarter of fiscal 2003. The adoption of FIN 45 did not have a material effect on the Company’s consolidated financial statements. The following is a summary of the Company’s agreements that are within the scope of FIN 45.

7


Table of Contents

Product Warranty

The Company provides for the estimated cost of product warranties at the time revenue is recognized. Given the Company’s limited operating history, the Company uses historical industry solar panel failure rates as the basis for the accrued warranty costs during the period. While the Company engages in product quality programs and processes, including monitoring and evaluating the quality of component suppliers, its warranty obligation is affected by product failure rates and material usage and service delivery costs incurred in correcting a product failure. If the Company’s actual product failure rates, material usage or service delivery costs differ from these estimates, accrued warranty costs would be adjusted in the period that such events or costs become known. Since the Company has a limited operating history and its manufacturing process differs from industry standards, its experience may be different from the industry data used as a basis for its estimate. While the Company’s methodology takes into account these uncertainties, adjustments in future periods may be required as its products mature. The following table summarizes the activity regarding the Company’s warranty accrual during the first nine months of 2003:

         
Balance at December 31, 2002
  $ 326,000  
Accruals for warranties issued during the period
    84,000  
Settlements made during the period
     
 
   
 
Balance at the end of the period
  $ 410,000  
 
   
 

Indemnification Agreements

The Company enters into standard indemnification agreements in its ordinary course of business. Pursuant to these agreements, the Company indemnifies, holds harmless, and agrees to reimburse the indemnified party for losses suffered or incurred by the indemnified party, generally our business partners, directors and officers. The term of these indemnification agreements is generally perpetual any time after execution of the agreement. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements under certain circumstances may be unlimited. However, the Company has never incurred costs to defend lawsuits or settle claims related to these indemnification agreements. Furthermore, the Company has a director and officer insurance policy pursuant to which the Company may recover all or a portion of amounts it pays to directors and officers under their indemnification agreements. As a result of the Company’s insurance policy coverage, the Company believes the estimated fair value of these indemnification agreements is minimal. The Company believes the estimated fair value of agreements with parties other than its directors and officers is minimal as well.

The Company agreed to indemnify, defend and hold harmless each of the purchasers participating in the Company’s Series A private placement financing transaction, their affiliates and their respective officers, directors, agents, employees, subsidiaries, partners, members and controlling persons to the fullest extent permitted by law from and against any and all losses, claims or written threats thereof, damages, expenses (including reasonable fees, disbursements and other charges of counsel) resulting from or arising out of the Company’s breach of any representation or warranty, covenant or agreement in the purchase agreement. The Company believes the estimated fair value of this indemnification agreement is minimal.

7.     Deferred Compensation and Equity Related Charges

Prior to December 31, 2000, the Company recorded total cumulative deferred compensation of approximately $1.3 million, representing the difference between the fair market value of the Company’s common stock and the exercise price on the option grant date. These amounts were presented as a reduction of stockholders’ equity and are being amortized ratably over the vesting period of the options, which is generally four years. The amortization resulted in charges to operations of $207,000 and $215,000 for the nine months ended September 30, 2003 and 2002, respectively.

8.     Stock Based Compensation

The Company applies the accounting provisions of Accounting Principles Board (“APB”) Opinion 25 and related interpretations and has elected the disclosure-only alternative permitted under Statement of Financial Accounting Standards Board (“SFAS”) No. 123, “Accounting for Stock-Based Compensation.” The Company has disclosed herein pro forma net loss using the fair value based method. All stock-based awards to non-employees are accounted for at their fair market value, as calculated using the Black-Scholes model in accordance with SFAS No. 123.

8


Table of Contents

Had compensation expense for the employee stock option plan been determined based on the fair value at the grant dates for options granted under the plan consistent with the method of SFAS No. 123, net loss would have been as follows (in thousands, except per share data):

                                 
    Three Months Ended
   
    September 30, 2003   September 30, 2002
   
 
    Net Loss   Net Loss   Net Loss   Net Loss
    Attributable   Per   Attributable   Per
    To Common   Common   To Common   Common
    Stockholders   Share   Stockholders   Share
   
 
 
 
Net loss attributed to common stockholders, as reported
  $ (4,008 )   $ (0.35 )   $ (2,732 )   $ (0.24 )
Add: Stock-based employee compensation expense included in reported results
    69       0.01       72       0.01  
Deduct: Total stock-based employee compensation expense determined under the fair value-based method for all awards
    (289 )